|
Tippi MacKenzie |
University of California, San Francisco |
Phase 1 |
Enrolling by invitation |
10 |
|
- Severe Combined Immunodeficiency, Artemis deficient (ART-SCID)
|
Morton Cowan |
University of California, San Francisco |
Phase 1 |
Recruiting |
25 |
|
|
Mark Walters |
University of California, San Francisco |
Phase 1 |
Launching |
N/A |
|
- Immune Disease
- Pediatrics
- X-linked Chronic Granulomatous Disease
|
Donald Kohn |
University of California, Los Angeles |
Phase 1/2 |
Active, not recruiting |
16 |
|
|
Donald Kohn |
University of California, Los Angeles |
Phase 1 |
Recruiting |
6 |
|
|
Donald Kohn |
University of California, Los Angeles |
Phase 2 |
Completed |
10 |
|
- Anemia
- Bone Marrow Transplant and Viral Infection
|
Alice Bertaina |
Stanford University |
Phase 1/2 |
Launching |
N/A |
|
|
Matthew Porteus |
Stanford University |
Phase 1/2 |
Launching |
N/A |
|
|
Judith Shizuru |
Stanford University |
Phase 1/2 |
Recruiting |
40 |
|
|
Rosa Bacchetta |
Stanford University |
Phase 1 |
Recruiting |
36 |
|
|
Stephen Gottschalk |
St. Jude Children's Research Hospital |
Phase 1/2 |
Suspended |
28 |
|
|
Bettina Cockroft |
Sangamo BioSciences, Inc. |
Phase 1/2 |
Completed |
5 |
|
- Immune Disease
- Leukocyte Adhesion Deficiency
|
Kinnari Patel |
Rocket Pharmaceuticals, Inc. |
Phase 1/2 |
Active, not recruiting |
9 |
|
|
Pierre Caudrelier |
ExCellThera Inc. |
Phase 1 |
Withdrawn |
N/A |
|
|
De-Fu Zeng |
City of Hope, Beckman Research Institute |
Phase 1 |
Active, not recruiting |
3 |
|
|
Michael Pulsipher |
Children's Hospital of Los Angeles |
Phase 1/2 |
Active, not recruiting |
60 |
|
|
David Williams |
Boston Children's Hospital |
Phase 2 |
Active, not recruiting |
10 |
|